{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:29:45Z","timestamp":1792794585332,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302431"],"award-info":[{"award-number":["82302431"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Central Plains Leading Talent Program (Science and Technology Innovation) of Henan Province","award":["264200510003"],"award-info":[{"award-number":["264200510003"]}]},{"name":"Luzhou Science and Technology Program","award":["2025RCX002"],"award-info":[{"award-number":["2025RCX002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04634-5","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:56:52Z","timestamp":1780559812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acid-enhanced drinkable hydrogel co-delivering riboflavin-loaded nanozymes for orchestrated inflammation-immune modulation and redox homeostasis in colitis therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenting","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakandar","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiChao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"4634_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2147\/PGPM.S536459","volume":"18","author":"S Bu","year":"2025","unstructured":"Bu S, Cheng X, Chen M, Yu Y. Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies. Pharmacogenomics Pers Med. 2025;18:219\u201338. https:\/\/doi.org\/10.2147\/PGPM.S536459.","journal-title":"Pharmacogenomics Pers Med"},{"issue":"1","key":"4634_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/ibd\/izaf195","volume":"32","author":"A Yarur","year":"2026","unstructured":"Yarur A, Irving P, Siegmund B, Dubinsky MC, Ananthakrishnan AN, Regueiro M, et al. Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid. Inflamm Bowel Dis. 2026;32(1):77\u201386. https:\/\/doi.org\/10.1093\/ibd\/izaf195.","journal-title":"Inflamm Bowel Dis"},{"key":"4634_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41575-025-01097-1","volume":"22","author":"GG Kaplan","year":"2025","unstructured":"Kaplan GG. The global burden of inflammatory bowel disease: from 2025 to 2045. Nat Rev Gastroenterol Hepatol. 2025;22:708\u201320. https:\/\/doi.org\/10.1038\/s41575-025-01097-1.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"47","key":"4634_CR4","doi-asserted-by":"publisher","first-page":"7457","DOI":"10.3748\/wjg.v11.i47.7457","volume":"11","author":"MJ Zou","year":"2005","unstructured":"Zou MJ, Cheng G, Okamoto H, Hao XH, An F, Cui FD, et al. Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates. World J Gastroenterol. 2005;11(47):7457\u201360. https:\/\/doi.org\/10.3748\/wjg.v11.i47.7457.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4634_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12951-024-02724-w","volume":"22","author":"S Tang","year":"2024","unstructured":"Tang S, Wang W, Wang Y, Gao Y, Dai K, Zhang W, et al. Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy. J Nanobiotechnol. 2024;22(1):468. https:\/\/doi.org\/10.1186\/s12951-024-02724-w.","journal-title":"J Nanobiotechnol"},{"key":"4634_CR6","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1007\/s12274-024-6757-4","volume":"17","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu J, Yuan S, You Y, Hu Q. Double-layer probiotic encapsulation for enhanced bacteriotherapy against inflammatory bowel disease. Nano Res. 2024;17:9103\u201310. https:\/\/doi.org\/10.1007\/s12274-024-6757-4.","journal-title":"Nano Res"},{"issue":"1","key":"4634_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10238-025-01558-6","volume":"25","author":"A Aljabri","year":"2025","unstructured":"Aljabri A, Soliman GM, Ramadan YN, Medhat MA, Hetta HF. Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems. Clin Exp Med. 2025;25(1):107. https:\/\/doi.org\/10.1007\/s10238-025-01558-6.","journal-title":"Clin Exp Med"},{"issue":"1","key":"4634_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ueg2.12745","volume":"70","author":"Y Ingrasciotta","year":"2024","unstructured":"Ingrasciotta Y, Grova M, Crispino F, Isgr\u00f2 V, Calapai F, Macaluso FS, et al. Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients. Minerva Gastroenterol. 2024;70(1):98\u2013108. https:\/\/doi.org\/10.1002\/ueg2.12745.","journal-title":"Minerva Gastroenterol"},{"key":"4634_CR9","doi-asserted-by":"publisher","first-page":"126546","DOI":"10.1016\/j.ijpharm.2025.126546","volume":"690","author":"H Lu","year":"2026","unstructured":"Lu H, Zhang W, Wu Z, Peng Y, Liu F, Gao S, et al. Advances and prospects of microenvironment-targeted nanotherapeutics for ulcerative colitis: evolving paradigms in the precision gut microenvironment. Int J Pharm. 2026;690:126546. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126546.","journal-title":"Int J Pharm"},{"key":"4634_CR10","doi-asserted-by":"publisher","first-page":"7192646","DOI":"10.1155\/2018\/7192646","volume":"2018","author":"SS Cao","year":"2018","unstructured":"Cao SS. Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2018;2018:7192646. https:\/\/doi.org\/10.1155\/2018\/7192646.","journal-title":"Gastroenterol Res Pract"},{"key":"4634_CR11","doi-asserted-by":"publisher","first-page":"1723606","DOI":"10.3389\/fphar.2025.1723606","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zeng L. Immune modulation in inflammatory bowel disease: therapeutic promise of baicalein. Front Pharmacol. 2025;16:1723606. https:\/\/doi.org\/10.3389\/fphar.2025.1723606.","journal-title":"Front Pharmacol"},{"issue":"10","key":"4634_CR12","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.12998\/wjcc.v12.i10.1718","volume":"12","author":"A Me\u0161trovi\u0107","year":"2024","unstructured":"Me\u0161trovi\u0107 A, Kumric M, Bozic J. Discontinuation of therapy in inflammatory bowel disease: Current views. World J Clin Cases. 2024;12(10):1718\u201327. https:\/\/doi.org\/10.12998\/wjcc.v12.i10.1718.","journal-title":"World J Clin Cases"},{"issue":"11","key":"4634_CR13","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1017\/S0007114514000178","volume":"111","author":"M Ashoori","year":"2014","unstructured":"Ashoori M, Saedisomeolia A. Riboflavin (vitamin B\u2082) and oxidative stress: a review. Br J Nutr. 2014;111(11):1985\u201391. https:\/\/doi.org\/10.1017\/S0007114514000178.","journal-title":"Br J Nutr"},{"issue":"6","key":"4634_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/microorganisms10061168","volume":"10","author":"KS Hossain","year":"2022","unstructured":"Hossain KS, Amarasena S, Mayengbam S. B Vitamins and Their Roles in Gut Health. Microorganisms. 2022;10(6):1168. https:\/\/doi.org\/10.3390\/microorganisms10061168.","journal-title":"Microorganisms"},{"issue":"3","key":"4634_CR15","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/ijms21030950","volume":"21","author":"N Suwannasom","year":"2020","unstructured":"Suwannasom N, Kao I, Pru\u00df A, Georgieva R, B\u00e4umler H. Riboflavin: The Health Benefits of a Forgotten Natural Vitamin. Int J Mol Sci. 2020;21(3):950. https:\/\/doi.org\/10.3390\/ijms21030950.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4634_CR16","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.3390\/molecules22122151","volume":"22","author":"F Castellano","year":"2017","unstructured":"Castellano F, Molinier-Frenkel V. An Overview of l-Amino Acid Oxidase Functions from Bacteria to Mammals: Focus on the Immunoregulatory Phenylalanine Oxidase IL4I1. Molecules. 2017;22(12):2151. https:\/\/doi.org\/10.3390\/molecules22122151.","journal-title":"Molecules"},{"issue":"10","key":"4634_CR17","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1590\/s0100-879x2003001000019","volume":"36","author":"CG Coimbra","year":"2003","unstructured":"Coimbra CG, Junqueira VB. High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson\u2019s disease patients. Braz J Med Biol Res. 2003;36(10):1409\u201317. https:\/\/doi.org\/10.1590\/s0100-879x2003001000019.","journal-title":"Braz J Med Biol Res"},{"key":"4634_CR18","doi-asserted-by":"publisher","first-page":"103778","DOI":"10.1016\/j.redox.2025.103778","volume":"85","author":"J Yayun","year":"2025","unstructured":"Yayun J, Qianqian G, Xihang S, Yang H, Zhenping H, Yuying L, et al. Metal-organic framework-mediated antioxidant enzyme delivery in disease treatment. Redox Biol. 2025;85:103778. https:\/\/doi.org\/10.1016\/j.redox.2025.103778.","journal-title":"Redox Biol"},{"issue":"Pt A","key":"4634_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcis.2024.08.154","volume":"678","author":"J Zhang","year":"2025","unstructured":"Zhang J, Xu X, Wei H, Wu D, Zeng L. Pt\/Pd dual-modified porphyrin metal-organic frameworks for NIR-II photothermal-enhanced photodynamic\/catalytic therapy. J Colloid Interface Sci. 2025;678(Pt A):42\u201352. https:\/\/doi.org\/10.1016\/j.jcis.2024.08.154.","journal-title":"J Colloid Interface Sci"},{"issue":"23","key":"4634_CR20","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.3390\/molecules28237703","volume":"28","author":"H Cheng","year":"2023","unstructured":"Cheng H. One-Pot Preparation of HCPT@IRMOF-3 Nanoparticles for pH-Responsive Anticancer Drug Delivery. Molecules. 2023;28(23):7703. https:\/\/doi.org\/10.3390\/molecules28237703.","journal-title":"Molecules"},{"issue":"1","key":"4634_CR21","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.1038\/s41598-019-47314-1","volume":"9","author":"HV Doan","year":"2019","unstructured":"Doan HV, Sartbaeva A, Eloi JC, Ting SAD. Defective hierarchical porous copper-based metal-organic frameworks synthesised via facile acid etching strategy. Sci Rep. 2019;9(1):10887. https:\/\/doi.org\/10.1038\/s41598-019-47314-1.","journal-title":"Sci Rep"},{"issue":"15","key":"4634_CR22","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1021\/acs.nanolett.4c04628","volume":"25","author":"Z Wan","year":"2025","unstructured":"Wan Z, Chung CHY, Lau CML, Chung JT, Chau Y, Fan Z, et al. Metal\u2013Organic Frameworks-Based Microrockets for Controlled and Sustained Drug Release. Nano Lett. 2025;25(15):5989\u201396. https:\/\/doi.org\/10.1021\/acs.nanolett.4c04628.","journal-title":"Nano Lett"},{"key":"4634_CR23","doi-asserted-by":"publisher","first-page":"123300","DOI":"10.1016\/j.carbpol.2025.123300","volume":"354","author":"H Zhao","year":"2025","unstructured":"Zhao H, Abbas S, Ren J, Huang H, Song Y, Su X, et al. Dextran from human feces-derived Weissella cibaria facilitates intestinal mucosal barrier function by modulating gut bacteria and propionate levels. Carbohydr Polym. 2025;354:123300. https:\/\/doi.org\/10.1016\/j.carbpol.2025.123300.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"4634_CR24","doi-asserted-by":"publisher","first-page":"2041342","DOI":"10.1080\/19490976.2022.2041342","volume":"14","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Maynard CL. Mucus, commensals, and the immune system. Gut Microbes. 2022;14(1):2041342. https:\/\/doi.org\/10.1080\/19490976.2022.2041342.","journal-title":"Gut Microbes"},{"issue":"1","key":"4634_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/iid3.1092","volume":"13","author":"V Singh","year":"2022","unstructured":"Singh V, Johnson K, Yin J, Lee S, Lin R, Yu H, et al. Chronic Inflammation in Ulcerative Colitis Causes Long-Term Changes in Goblet Cell Function. Cell Mol Gastroenterol Hepatol. 2022;13(1):219\u201332. https:\/\/doi.org\/10.1002\/iid3.1092.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"4634_CR26","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41467-024-45539-x","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu J, Xu X, Duan J, Chai Y, Song J, Gong D, et al. EFHD2 suppresses intestinal inflammation by blocking intestinal epithelial cell TNFR1 internalization and cell death. Nat Commun. 2024;15(1):1282. https:\/\/doi.org\/10.1038\/s41467-024-45539-x.","journal-title":"Nat Commun"},{"key":"4634_CR27","doi-asserted-by":"publisher","first-page":"102469","DOI":"10.1016\/j.redox.2022.102469","volume":"56","author":"J Zhang","year":"2022","unstructured":"Zhang J, Cen L, Zhang X, Tang C, Chen Y, Zhang Y, et al. MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT. Redox Biol. 2022;56:102469. https:\/\/doi.org\/10.1016\/j.redox.2022.102469.","journal-title":"Redox Biol"},{"key":"4634_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.actbio.2025.04.016","volume":"198","author":"Y Chen","year":"2025","unstructured":"Chen Y, Bi S, Zhang X, Chen J, Xin J, Liu Z, et al. Engineered probiotics remodel the intestinal epithelial barrier and enhance bacteriotherapy for inflammatory bowel diseases. Acta Biomater. 2025;198:467\u201381. https:\/\/doi.org\/10.1016\/j.actbio.2025.04.016.","journal-title":"Acta Biomater"},{"key":"4634_CR29","doi-asserted-by":"publisher","first-page":"1719366","DOI":"10.3389\/fimmu.2025.1719366","volume":"16","author":"Z Wu","year":"2025","unstructured":"Wu Z, Wang X, Guan Z, Han M, Ma W, Li J, et al. Deciphering the immunocellular regulatory network in inflammatory bowel disease: from susceptibility genes to cellular effectors and toward precision therapies. Front Immunol. 2025;16:1719366. https:\/\/doi.org\/10.3389\/fimmu.2025.1719366.","journal-title":"Front Immunol"},{"key":"4634_CR30","doi-asserted-by":"publisher","unstructured":"Olbei M, Hautefort I, Thomas JP, Csabai L, Bohar B, Koigi SS, et al. Decoding cytokine networks in ulcerative colitis to identify pathogenic mechanisms and therapeutic targets. Sci Signal. 2026;19(923). https:\/\/doi.org\/10.1126\/scisignal.adt0986.","DOI":"10.1126\/scisignal.adt0986"},{"issue":"21","key":"4634_CR31","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1039\/d2tb00300g","volume":"10","author":"H Zhao","year":"2022","unstructured":"Zhao H, Du Y, Liu L, Du Y, Cui K, Yu P, et al. Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis. J Mater Chem B. 2022;10(21):4002\u201311. https:\/\/doi.org\/10.1039\/d2tb00300g.","journal-title":"J Mater Chem B"},{"key":"4634_CR32","doi-asserted-by":"publisher","unstructured":"Wu H, Pang MM, Li YL, Huang JJ, Geng SZ, Hong JH, et al. Flos sophorae immaturus exosome-like nanovesicles alleviate ulcerative colitis by attenuating intestinal oxidative stress and inflammation through activating Aryl hydrocarbon receptor via gut microbiota and tryptophan metabolism regulation. J Nanobiotechnol. 2026;24. https:\/\/doi.org\/10.1186\/s12951-026-04083-0.","DOI":"10.1186\/s12951-026-04083-0"},{"key":"4634_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bioactmat.2024.02.033","volume":"36","author":"J Li","year":"2024","unstructured":"Li J, Song J, Deng Z, Yang J, Wang X, Gao B, et al. Robust reactive oxygen species modulator hitchhiking yeast microcapsules for colitis alleviation by trilogically intestinal microenvironment renovation. Bioact Mater. 2024;36:203\u201320. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.02.033.","journal-title":"Bioact Mater"},{"issue":"8","key":"4634_CR34","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1039\/d4fo00835a","volume":"15","author":"WW Zhang","year":"2024","unstructured":"Zhang WW, Thakur K, Zhang JG, Wei ZJ. Riboflavin ameliorates intestinal inflammation via immune modulation and alterations of gut microbiota homeostasis in DSS-colitis C57BL\/6 mice. Food Funct. 2024;15(8):4109\u201321. https:\/\/doi.org\/10.1039\/d4fo00835a.","journal-title":"Food Funct"},{"key":"4634_CR35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/gutjnl-2025-335626","volume":"75","author":"J Zhang","year":"2026","unstructured":"Zhang J, Mak JWY, Ng SC. Gut microbiome in IBD: past, present and the future. Gut. 2026;75:398\u2013410. https:\/\/doi.org\/10.1136\/gutjnl-2025-335626.","journal-title":"Gut"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04634-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04634-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04634-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:35:47Z","timestamp":1786332947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04634-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4634"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04634-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval Animal protocols were approved by the Animal Care and Use Committee of Zhengzhou University (ZZU-LAC20231222 [\n                      \n                      ]).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors of this study agreed to publish.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"738"}}